SMTL ID : 6rz6.1

Crystal structure of the human cysteinyl leukotriene receptor 2 in complex with ONO-2570366 (C2221 space group)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.43 Å

Oligo State

monomer

Ligands

1 x KNW: (2~{S})-8-[[4-[4-(2-chloranyl-5-fluoranyl-phenyl)butoxy]phenyl]carbonylamino]-4-(4-oxidanyl-4-oxidanylidene-butyl)-2,3- dihydro-1,4-benzoxazine-2-carboxylic acid(Non-covalent)

KNW.1: 23 residues within 4Å: Chain A: K.21, F.25, Y.103, Y.107, Y.111, S.153, S.154, L.172, L.174, K.178, L.182, M.185, N.186, I.188, A.189, V.192, G.193, R.350, H.353, L.354, H.367, L.370 Ligands: OLC.15 19 PLIP interactions: 19 interactions with chain A Hydrophobic interactions: A:Y.103, A:Y.107, A:L.182, A:M.185, A:V.192, A:R.350, A:L.354, A:L.370 Hydrogen bonds: A:Y.103, A:Y.103, A:Y.103 Water bridges: A:K.21, A:K.21, A:Y.82, A:L.172, A:E.173 Salt bridges: A:K.21, A:K.178, A:H.367

1 x CLR: CHOLESTEROL(Non-covalent)

CLR.2: 3 residues within 4Å: Chain A: S.202, Y.205, I.209 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:Y.205, A:I.209

1 x TLA: L(+)-TARTARIC ACID(Non-covalent)

TLA.3: 7 residues within 4Å: Chain A: R.326, K.327, G.392, N.394, F.395, K.396, D.397 10 PLIP interactions: 10 interactions with chain A Hydrogen bonds: A:K.327, A:G.392, A:G.392, A:N.394, A:F.395, A:K.396, A:D.397, A:D.397 Salt bridges: A:R.326, A:K.327

16 x OLC: (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate(Non-covalent)(Non-functional Binders)

OLC.4: 7 residues within 4Å: Chain A: F.20, E.23, F.24, I.27, V.28 Ligands: OLC.5, OLC.12 Ligand excluded by PLIP OLC.5: 13 residues within 4Å: Chain A: F.20, F.24, I.31, I.32, K.368, I.372, A.375, L.376, A.379, F.383 Ligands: OLC.4, OLC.7, OLC.12 Ligand excluded by PLIP OLC.6: 6 residues within 4Å: Chain A: F.33, P.76, D.80, L.83, R.84 Ligands: OLC.11 Ligand excluded by PLIP OLC.7: 5 residues within 4Å: Chain A: V.35, G.39, C.382, F.383 Ligands: OLC.5 Ligand excluded by PLIP OLC.8: 7 residues within 4Å: Chain A: F.199, T.200, I.203, C.204, L.207 Ligands: OLC.19, OLA.21 Ligand excluded by PLIP OLC.9: 5 residues within 4Å: Chain A: F.198, F.199, S.202, L.206 Ligands: OLA.20 Ligand excluded by PLIP OLC.10: 5 residues within 4Å: Chain A: V.37, G.41, L.42, Y.45 Ligands: OLA.24 Ligand excluded by PLIP OLC.11: 6 residues within 4Å: Chain A: P.76, F.77, D.80, R.84 Ligands: OLC.6, OLA.26 Ligand excluded by PLIP OLC.12: 3 residues within 4Å: Chain A: L.341 Ligands: OLC.4, OLC.5 Ligand excluded by PLIP OLC.13: 10 residues within 4Å: Chain A: L.212, E.216, L.322, H.325, R.326, L.329, T.330, I.333 Ligands: OLA.23, OLA.28 Ligand excluded by PLIP OLC.14: 4 residues within 4Å: Chain A: Y.205, I.333 Ligands: OLC.18, OLA.23 Ligand excluded by PLIP OLC.15: 6 residues within 4Å: Chain A: Y.111, L.149, I.188, V.192 Ligands: KNW.1, OLC.19 Ligand excluded by PLIP OLC.16: 4 residues within 4Å: Chain A: L.48, L.62, I.66, W.140 Ligand excluded by PLIP OLC.17: 7 residues within 4Å: Chain A: F.77, I.89, F.90, G.91, A.94, M.98 Ligands: OLA.25 Ligand excluded by PLIP OLC.18: 1 residues within 4Å: Ligands: OLC.14 Ligand excluded by PLIP OLC.19: 6 residues within 4Å: Chain A: Y.111, T.114, V.115, T.200 Ligands: OLC.8, OLC.15 Ligand excluded by PLIP

10 x OLA: OLEIC ACID(Non-covalent)(Non-functional Binders)

OLA.20: 6 residues within 4Å: Chain A: Y.187, L.190, V.191, L.196, T.351 Ligands: OLC.9 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:Y.187, A:L.190, A:V.191, A:T.351 OLA.21: 5 residues within 4Å: Chain A: Y.121, L.196, F.199 Ligands: OLC.8, OLA.22 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:L.196, A:F.199 Hydrogen bonds: A:Y.121 OLA.22: 3 residues within 4Å: Chain A: L.207, R.210 Ligands: OLA.21 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:L.207 Salt bridges: A:R.210 OLA.23: 7 residues within 4Å: Chain A: Y.205, L.212, L.213, E.216, L.336 Ligands: OLC.13, OLC.14 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:Y.205, A:L.336 Hydrogen bonds: A:E.216 OLA.24: 4 residues within 4Å: Chain A: L.42, Y.45, A.402 Ligands: OLC.10 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:L.42, A:Y.45 OLA.25: 1 residues within 4Å: Ligands: OLC.17 No protein-ligand interaction detected (PLIP) OLA.26: 4 residues within 4Å: Chain A: Y.45, L.48, Q.49 Ligands: OLC.11 3 PLIP interactions: 3 interactions with chain A Hydrophobic interactions: A:Y.45, A:L.48 Hydrogen bonds: A:Q.49 OLA.27: 8 residues within 4Å: Chain A: S.67, L.70, F.71, S.101, N.105, W.140, W.147, M.151 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:L.70, A:L.70, A:N.105, A:W.140, A:W.147 OLA.28: 5 residues within 4Å: Chain A: I.337, L.386, F.390 Ligands: OLC.13, OLA.29 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:I.337, A:L.386, A:F.390, A:F.390 OLA.29: 2 residues within 4Å: Chain A: F.390 Ligands: OLA.28 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:F.390

1 x 1PE: PENTAETHYLENE GLYCOL(Non-functional Binders)

1PE.30: 7 residues within 4Å: Chain A: E.216, L.219, E.220, N.315, I.318, Q.319, L.322 1 PLIP interactions: 1 interactions with chain A Water bridges: A:E.216

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gusach, A. et al., Structural basis of ligand selectivity and disease mutations in cysteinyl leukotriene receptors. Nat Commun (2019)

Release Date

2019-12-11

Peptides

Cysteinyl leukotriene receptor 2,Soluble cytochrome b562,Cysteinyl leukotriene receptor 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Cysteinyl leukotriene receptor 2,Soluble cytochrome b562,Cysteinyl leukotriene receptor 2

Related Entries With Identical Sequence